Transmural heterogeneity of myocardial metabolism and function are present in the left ventricle under normal and ischemic conditions. To determine if endocardial versus epicardial differences of [Ca2`11 are also present, perfused rat heart studies using indo-1 fluorescence as an index of [Ca2"]i were performed in the left ventricular epicardium and endocardium. Hearts were studied during control conditions and low-flow ischemia. Results demonstrated the following: 1) At a pacing rate of 1.5 Hz, endocardial levels of diastolic and systolic [Ca2"]. (470+40 and 1,240+170 nM) were higher than epicardial levels (290±30 and 920±t150 nM). 2) At a more physiological pacing rate of 5 Hz, endocardial levels of diastolic and systolic [Ca2"]i (680±50 and 1,230±70 nM) were also higher than epicardial levels (390±20 and 950±60 nM). 3) During low-flow ischemia, endocardial levels of diastolic [Ca2+1 rose to a greater degree (from 680±50 to 1,050±70 nM at 10% of control coronary flow) compared with epicardial levels (from 390±20 to 580±40 nM at of control flow), suggesting that the endocardium is more susceptible to low-flow ischemia. 4) The amplitude of the [Ca2+I, transient was the same at the endocardium (540±50 nM) and epicardium (560±50 nM) and did not change during low-flow ischemia, despite marked contractile dysfunction. These findings are consistent with the hypothesis that endocardial versus epicardial differences of [Ca21I1 exist under normal and low-flow ischemic conditions and may, in part, account for the previous observations of transmural metabolic and functional gradients in the left ventricle of the whole heart. Furthermore, the contractile failure associated with low-flow ischemia is not due to a decrease of the [Ca 2+1 itransient amplitude. (Circulation Research 1993;72:1082-1090 KEY WoRDS * indo-1 * contractility * endocardium * epicardium P athological studies of patients with coronary artery disease have demonstrated that the endocardium has a greater degree of myocardial necrosis, fibrosis, and metabolic abnormalities than the epicardium."12 These findings suggest that the endocardium is more susceptible to ischemia than the epicardium. To determine the factors that predispose the endocardium to ischemic injury, investigators have examined the transmural distribution of numerous myocardial metabolic and functional parameters under nor- 
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injury, a transmural gradient of intracellular calcium may account for the greater susceptibility of the endocardium to ischemic injury. Although several studies have examined [Ca2+] i in perfused hearts under normal physiological conditions and during low-flow and noflow ischemia, 24 27 no previous study has measured [Ca2" ]I at both the epicardium and endocardium.
Therefore, the goals of the present study were 1) to use a novel technique recently developed in our laboratory28 to estimate [Ca21]i at both the epicardium and endocardium of the left ventricle in a perfused rat heart model of low-flow ischemia, 2) to test the hypothesis that endocardial versus epicardial differences of [Ca2+]i exist under normal physiological conditions, and 3) to test the hypothesis that endocardial versus epicardial differences of [Ca 2+]i develop during severe reductions of coronary flow. These hypotheses were tested in isolated perfused rat hearts using indo-1 calcium fluorescence to estimate [Ca21] i at the epicardium and endocardium during control and low-flow ischemic conditions.
Materials and Methods

Heart Perfusion and Measurement of Function
Male Sprague-Dawley rats (450-550 g) were heparinized (1,000 units i.p.) and anesthetized with ketamine 100 mg i.p. Hearts were excised and arrested in cold isosmotic saline (20 mM KCl) . Isolated hearts were perfused retrograde via the aorta at a constant pressure of 71 mm Hg with a Krebs-Heinseleit perfusate containing (mM) NaCl 118, KCl 6.0, CaCl2 2.5, NaHCO3 25, MgSO4 1.2, Na2-EDTA 0.5, glucose 4.0, and pyruvate 10.0, along with 20 units/l insulin. The perfusate was continuously bubbled with 95% 02-5% CO2 and maintained at 37°C. A compliant latex balloon attached to a Trantec pressure transducer (American Edwards Laboratories, Irvine, Calif.) via rigid polyethylene tubing was inserted into the left ventricle to measure pressure. Left ventricular diastolic pressure was set at approximately 10 mm Hg by adjusting balloon volume. Developed pressure was recorded on a series 8000 chart recorder (Gould Electronics, Hayward, Calif.). Hearts were paced at 1.5 (after removal of the sinoatrial node) or 5 Hz with two platinum-tipped electrodes connected to a stimulus generator (model SD-5, Grass Instrument Co., Quincy, Mass.). Coronary flow was measured by collecting the heart effluent. Coronary flow reductions were produced using an in-line flowmeter that controlled coronary perfusion pressure (Gilmont Instruments Inc., Barrington, Ill.). Fluorescence Measurements Fluorescence instrumentation. Fluorescence studies were performed with a modified spectrofluorometer (model 48000S, SLM Instruments Inc., Urbana, Ill.). Excitation light from a 450-W xenon arc lamp (SLM Instruments) was filtered through a 350-nm interference filter and focused onto the in-going leg of a quartz bifurcated fiber bundle. For epicardial measurements, the common leg of this 0.69-mm-diameter fiber bundle, with a fixed rubber hood (1.09 mm o.d.) protruding 1.5 mm past the fiber bundle end, was girdled against the epicardial surface of the left ventricle, avoiding visible vessels. For endocardial measurements, this same fiber bundle was passed through the left atrium and mitral valve onto the left ventricular endocardial surface above the pressure balloon. A nylon girdle about the heart was used to hold the fiber bundle in place relative to the heart. Repeated repositioning of the fiber bundle on different parts of the heart surface (both endocardium and epicardium) resulted in reproducible fluorescence intensities and transient ratios. A shutter in front of the excitation light was opened for only seconds at a time during data acquisition to prevent bleaching of indo-1 fluorescence. The fluorescent signal was transferred via the outgoing leg of the bundle and separated by a dichroic mirror onto two photomultiplier tubes preceded by 385-and 456-nm interference filters. imental Design" below). The mean background fluorescence intensities at control flow and during graded flow reductions were then determined. These mean background fluorescence intensities were used to correct the appropriate F385 and F456 fluorescence intensities in indo-1-loaded hearts subjected to identical coronary flow reductions before calculation of the corrected fluorescence ratio (see "Calcium transient determination" above).
In another set of experiments, background fluorescence intensities at control flow and during a coronary flow reduction to 10% of control flow were determined before indo-1 loading in a series of hearts subjected to the same coronary flow reduction (10% of control flow) after indo-1 loading (epicardium, n=5; endocardium, n=5). By using background fluorescence intensities from the same heart before indo-1 loading at control and at 10% of control flow, the corrected fluorescence ratio for each heart was calculated. Since both background fluorescence correction methods yielded nearly identical mean ratios, only data obtained using the first method are reported.
Bradykinin effect. A previous study by Lorell et a132 demonstrated a marked increase of the indo-1 fluorescence ratio in perfused rabbit hearts within 8-15 seconds of infusion with bradykinin, an endothelial cell calcium agonist. Therefore, to determine if bradykinin increased the indo-1 fluorescence signal in rat hearts, studies were performed comparing indo-1 calcium fluorescence measurements before and during a 3-minute infusion with perfusate containing 10-5 M bradykinin (epicardium, n=4; endocardium, n=5).
Confocal fluorescence microscopy. To determine if there was heterogeneous indo-1 loading of the endocardial or epicardial surface (i.e., due to endothelial cell loading), confocal microscopy experiments were carried out on fresh 4-mm-thick transverse sections of indo-1-loaded rat hearts. Methods were adapted from those previously described by Zen et al. 33 The endocardial rim was examined with an epifluorescence microscope (Leitz, Rockleigh, N.J.) equipped with a coaxial-confocal attachment (Technical Instrument Co., San Francisco). The endocardial surface was viewed with a x25 long-working-distance objective with a numerical aperture of 0.35 (Leitz) and a x60 oil immersion objective with a numerical aperture of 1.4 (Nikon, Garden City, N.J.). The light source was a stabilized Hg-Xe arc lamp (100 W) equipped with a standard broadband ultraviolet filter set.
Standardization of indo-1 fluorescence data. To determine if there were differences in the tissue filter effect that could result in spurious differences of the corrected fluorescence ratio between the epicardium and endocardium, the ratio was measured at both surfaces under conditions of saturating [Ca2+]I and total metabolic inhibition (Rmax). The finding that Rma,x is similar at the epicardium and endocardium would suggest that there was no difference in the tissue filter effect; thus, direct comparison of the epicardial and endocardial ratio is appropriate.
Rma, was determined by subjecting a series of indo-1-loaded hearts (endocardium, n = 4; epicardium, n = 4) tofused rat hearts (approximately 6 g wet wt) and 15 ml HEPES (5 mM) perfusate containing 20 mM NaCI, 115 mM KCl, and 75 ,uM indo-1 free acid. Homogenate solutions were prepared using a Polytron blender (Brinkmann Instruments, Ontario, Canada) and ultracentrifugation (100,000g for 1 hour). Before fluorescence measurements, either 20 mM EGTA (calciumfree indo-1) or 20 mM CaCI2 (calcium-saturated indo-1) was added to this solution and placed in a cuvette (solutions corrected to pH 7.1). The isosbestic points for indo-1 in the heart homogenate and whole-heart fluorescence studies were similar (approximately 429 nm).
S385f/S385b and S456f/S456b were then calculated from the indo-1 fluorescence intensities at emission wavelengths of 385 and 456 nm, respectively, for the calciumfree (S385f and S456f) and calcium-saturated (S385b and S456b) cuvette solutions.
Experimental Design After indo-1 loading and baseline measurements of coronary flow, developed pressure, and F385 and F456, hearts (n=8) were subjected to a 2.6-minute period of a coronary flow reduction (50%, 20%, or 10% of control flow), at which time measurements of coronary flow, developed pressure, and F385 and F456 were repeated. This 2.6-minute acquisition time was previously demonstrated in this laboratory28 to be the time at which a steady state was reached for approximately 30 seconds for developed pressure, high-energy phosphate metabolites, and F385 and F456, but of a short enough duration to prevent myocardial stunning or damage. A 15-minute recovery period followed each flow reduction, which allowed coronary flow and developed pressure to return to baseline levels. Baseline measurements were repeated before each of the flow reductions, which were performed in random order. This protocol was performed at both the epicardium (n =5) or at the endocardium (n =5) in a random order. At the end of each experiment, a set of control measurements was taken.
All studies were approved by the institutional animal experimentation committee and adhered to the guidelines set out by the National Institutes of Health guide for the care and use of laboratory animals.
Statistical Analyses
Values are reported as mean±SEM. Statistical analyses were performed using paired t tests, repeatedmeasures analysis of variance, or linear regression, when indicated. Results were considered significant at p<0.05. Results not found to be statistically significant were reported asp=NS.
Results
Heart Function
Loading with indo-1 resulted in a 33% decrease of baseline developed pressure from 92±3 to 61±4 mm Hg but had no effect on control diastolic pressure (10+1 mm Hg) or coronary flow (14.2±0.6 ml/g wet wt). There was no difference in control coronary flow or developed pressure between groups of hearts studied at the epicardium and endocardium. Reductions of coronary flow to 50%, 20%n, and 10% of control flow produced exsure in both unloaded and indo-1-loaded hearts. No differences between epicardial and endocardial experiments were observed in the fall of developed pressure after coronary flow reductions. Control measurements of coronary flow and diastolic pressure at the conclusion of experiments were unchanged when compared with baseline measurements before flow reductions. Developed pressure decreased approximately 8% over the course of each experiment.
Background (NADH) Fluorescence Changes
Control background fluorescence intensities were found to be similar and reproducible at the endocardium (F385, 0.57+0.02 intensity units; F456, 0.61+±0.02 intensity units; n = 13) and epicardium (F385, 0.57+ 0.03 intensity units; F456, 0.58±0.04 intensity units; n=13) (p=NS for endocardial versus epicardial). The percent increase of background fluorescence during coronary flow reductions to 50%, 20%, and 10% of control flow (primarily due to increased NADH) tended to be greater at the endocardium than at the epicardium but did not reach statistical significance (n=5). Background fluorescence at F456 increased 5 + 1% at the epicardium versus 8+1% at the endocardium at 50% of control flow; 17+2% versus 20±2%, respectively, at 20% of control flow; and 33+7% versus 40+5%, respectively, at 10% of control flow. It should be noted that subtraction of these increases in background fluorescence from the indo-1 signal during low-flow ischemia results in a reduction of the indo-1 fluorescence intensities of only 0.5-2.3% after background correction. This is the result of 12 times indo-1 loading compared with background fluorescence levels at 385 nm.
Potential Nonmyocyte Contribution to Indo-1 Fluorescence
To examine the potential contribution of alterations in endothelial cell calcium during ischemia to the indo-1 fluorescence signal in perfused rat hearts, indo-1-loaded hearts were perfused with bradykinin (10`5 M) to abruptly increase endothelial cytosolic calcium. Bradykinin is known to produce a vasodilatory response in rat endothelium that is mediated through an increase in endothelial cytosolic calcium, which in turn increases endothelium-derived relaxing factor activity. 36 Figure 2 shows Transmural gradients of coronary flow, metabolism, and mechanical function in the left ventricle have been extensively documented during low-flow and no-flow ischemia.8-10.12.14-22 Greater reductions of coronary flow8'18,2' and systolic contractile force21 and more marked alterations of energy metabolism14-20 occur at the endocardium than at the epicardium during lowflow and no-flow ischemia. Taken together, these previous studies strongly suggest that the endocardium is more prone to ischemia after an alteration of flow or substrate supply. Since intracellular calcium cycling is a highly energy-dependent process, transmural differischemia would be expected. In the present study, [40] [41] [42] In a perfused whole-heart preparation (with loading conditions similar to those of the present study), Lee et al43  found that very little of the Mn2+-quenchable indo-1 fluorescence was present in the mitochondria. It may be that the amount of compartmentation is due to different loading conditions (some cell preparations use much higher concentrations of indo-1) and/or differences in the myocyte's esterase efficiency between models. Further studies will be required to determine the importance of dye compartmentation when interpreting indo-1 calcium fluorescence data.
To demonstrate the magnitude of endocardial versus epicardial differences of indo-1 calcium fluorescence data in more quantitative terms, relative indo-1 fluorescence intensities were converted to absolute concentrations. There are a number of difficulties in quantitating 
